For the quarter ended September 2024, Novartis (NVS) reported revenue of $12.82 billion, up 8.8% over the same period last year. EPS came in at $2.06, compared to $1.74 in the year-ago quarter.The reported revenue represents a surprise of +1.63% over the Zacks Consensus Estimate of $12.62 billion. With the consensus EPS estimate being $1.94, the EPS surprise was +6.19%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expe ...